Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussion. J Interv Cardiol 2008 Aug;21(4):283-99
Date
08/30/2008Pubmed ID
18754964DOI
10.1111/j.1540-8183.2008.00375.xScopus ID
2-s2.0-47849101187 (requires institutional sign-in at Scopus site) 3 CitationsAbstract
With the availability of new data and the recent release of new European and US guidelines, contemporary care paradigms for the treatment of patients with non-ST-elevation acute coronary syndromes (NSTE ACS), including those undergoing percutaneous coronary intervention, are likely to undergo substantial changes. In recognition of this shifting landscape as well as the impact of new guidelines on care models for the treatment of patients with NSTE ACS, a roundtable was convened on October 25, 2007, to discuss the implications of these changes. The purpose of this review is to summarize the presentations and subsequent discussions from the roundtable, which examined the guidelines and evidence from a variety of perspectives, and to explore the best ways to incorporate new treatment paradigms into everyday clinical care. The multiple viewpoints expressed by the roundtable attendees illustrate the recognition that at this point, consensus has not been reached on the optimum algorithm for treatment of these patients. This article focuses on issues discussed during the roundtable from the perspective of the practicing cardiologist.
Author List
Cohen M, Hoekstra J, Giugliano R, Granger CB, Gurbel PA, Hollander JE, Manoukian SV, Pollack CV Jr, Saucedo JFAuthor
Jorge Saucedo MD Chief, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Acute Coronary SyndromeAlgorithms
Angioplasty, Balloon, Coronary
Anticoagulants
Aspirin
Cardiovascular Agents
Clinical Trials as Topic
Emergency Treatment
Evidence-Based Medicine
Fibrinolytic Agents
Hirudins
Humans
Peptide Fragments
Piperazines
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Postoperative Hemorrhage
Practice Guidelines as Topic
Prasugrel Hydrochloride
Recombinant Proteins
Risk Assessment
Stents
Thiophenes
Thrombosis
Ticlopidine